MAZ promotes tumor-associated angiogenesis by controlling genes like VEGF; its repression can be induced by factors such as oxidative stress and epigenetic changes, sustaining tumor growth and blood supply through pathways like STAT3 signaling [140]. This evidence concerns the gene STAT3 and neoplasm.